607-42-1Relevant articles and documents
1 - [...] synthetic preparation method
-
, (2019/02/13)
The invention discloses a 1 - [...] synthetic preparation method, comprises the following steps: S1) will anthracene and acetyl chloride is dissolved in the solvent, and the catalysis of a Lewis acid, reaction to obtain the 1 - b [...]; S2) 1 - b [...] through oxidation reaction, to obtain 1 - carboxylic acid anthracene; S3) under the action of the acyl, firstly the 1 - anthracene acid radical chloride acid, to remove the surplus solvent, followed by reaction with cyanide, to produce the target compound 1 - cyanate anthracene. The present invention provides 1 - [...] synthetic preparation method, in order to low-cost transfer catalyst, acetyl chloride as the raw material, after three step synthesis of simple and convenient operation, and then after treatment and purification, can prepare and get the purity 98% or more of 1 - [...], not only the production cost is low, the experimental steps are few, simple operation, and after the simple purification, the purity can reach 98% above, can fully meet the T - 2 toxin of the derivatization detection, greatly reduce the T - 2 toxin detection cost.
Use of Mineral/Organic Composite Material in the Form of an Ultraviolet Radiation Protective Agent
-
, (2009/05/29)
The invention relates to the use of composite material which comprises nanoparticles of a least one metal derivative and at least one organic sunscreen agent which is chemically bound with said particles in a covalent manner in the form of an ultraviolet radiation protective agent containing the inventive composite material. Cosmetic ultraviolet radiation protective compositions comprises said mixture are also disclosed.
Synthesis, DNA-damaging and cytotoxic properties of novel topoisomerase II-directed bisantrene analogues
Zagotto, Giuseppe,Oliva, Ambrogio,Guano, Fulvio,Menta, Ernesto,Capranico, Giovanni,Palumbo, Manlio
, p. 121 - 126 (2007/10/03)
New bisantrene analogues were synthesized, bearing one or two 4,5-dihydro-1H-imidazol-2-yl hydrazone side chains at positions 1,4 or 9 of the anthracene ring system. A 10-aza-bioisostere was also prepared. The position of substituents in structurally isomeric drugs modulates topoisomerase II poisoning and specificity, along with cytotoxicity.